CBC Group Deal History & Licensing Activity
CBC Group is a life sciences. Over the past three years, CBC Group has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Small Molecules
Focus Area
Mega Deals
CBC Group Recent Deal Activity
Licensing, acquisition, and partnership transactions involving CBC Group in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Zyrtec and Neupro (China neurology and allergy business) | UCB | Small Molecules | Approved | acquisition | May 2026 |
CBC Group Pipeline Focus
Therapeutic areas and modalities where CBC Group is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches CBC Group's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About CBC Group Licensing & Deal Activity
CBC Group is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, CBC Group ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for CBC Group include Mega Deals (2 deals and trials). In terms of modality, CBC Group has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for CBC Group and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against CBC Group's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.